Results 81 to 90 of about 8,239 (187)

IUCN Species Survival Commission Wild Tulip Specialist Group established

Oryx
Brett Wilson, Ormon Sultangaziev
doaj   +1 more source

Long-Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus. [PDF]

ACR Open Rheumatol
Vital EM, Amoura Z, Kalunian KC, Bruce IN, Tanaka Y, Manzi S, Hupka I, Knagenhjelm J, Al-Mossawi H, Lindholm C.   +9 more
europepmc   +1 more source

Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials. [PDF]

Lupus Sci Med
Doria A, van Vollenhoven RF, Morand EF, Mosca M, Nåtman J, Waratani M, Knagenhjelm J, Lindholm C, Kielar D.   +8 more
europepmc   +1 more source

Comparison of clinical performance among the I-Gel Proseal Lma and Tulip Oropharyngeal Airway. [PDF]

BMC Anesthesiol
Çimen O, Gültop F, Kale O, Arık E, Yarsan B, Baykal Z, Ergil J.   +6 more
europepmc   +1 more source

Removal of spinopelvic S2 alar-iliac osseointegrative screws: a case report and surgical technique guide. [PDF]

J Spine Surg
McDermott RM, Glover K, Patel V.
europepmc   +1 more source

Enhancing brachytherapy in cervical cancer: Initial dosimetric experience and assessment of Tulip hybrid applicator - the Add-On advantage. [PDF]

J Contemp Brachytherapy
Maniyar AI, Alva RC, Koushik K, Nithyanand S, Janaki MG, Revathy P, Ponni TRA, Kumar M, Lavanya ML.   +8 more
europepmc   +1 more source

Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study. [PDF]

Diabetes
Meier CZ, Wagner R, Ganslmeier M, Kantartzis K, Heni M, Peter A, Jumpertz-von Schwartzenberg R, Machann J, Schick F, Birkenfeld AL, Häring HU, Fritsche A, Stefan N.   +12 more
europepmc   +1 more source

The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis. [PDF]

Arthritis Care Res (Hoboken)
Brunner HI, Cody EM, Devarajan P, Huang B, Chen C, Sinibaldi D, Ramaswamy M, Knagenhjelm J, Jones F, Brohawn PZ, Tummala R, Lindholm C, White WI.   +12 more
europepmc   +1 more source

Transportability of the comparative effect of finerenone for the treatment of symptomatic chronic heart failure with left ventricular ejection fraction of ≥40%: insights from the FINEARTS-HF trial. [PDF]

J Comp Eff Res
Turner AJ, Leboucher C, Remuzat C, Fung YM, Pessina E, Folkerts K.   +5 more
europepmc   +1 more source

From Gut to Systemic Circulation: Molecular Strategies of Botulinum Neurotoxin Complexes. [PDF]

Toxins (Basel)
Mondy J, Lemichez E.
europepmc   +1 more source